| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds and Injuries | 11 | 2022 | 231 | 3.860 |
Why?
|
| Firearms | 9 | 2023 | 48 | 3.480 |
Why?
|
| Surgeons | 9 | 2024 | 238 | 2.990 |
Why?
|
| Violence | 10 | 2023 | 143 | 2.710 |
Why?
|
| Wounds, Gunshot | 10 | 2023 | 71 | 2.590 |
Why?
|
| Homicide | 5 | 2023 | 34 | 2.210 |
Why?
|
| Prisoners | 3 | 2021 | 40 | 2.070 |
Why?
|
| Traumatology | 4 | 2021 | 27 | 1.960 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2023 | 86 | 1.730 |
Why?
|
| Intimate Partner Violence | 4 | 2021 | 20 | 1.710 |
Why?
|
| Patient Readmission | 7 | 2021 | 329 | 1.670 |
Why?
|
| Wounds, Nonpenetrating | 4 | 2023 | 92 | 1.470 |
Why?
|
| Racism | 8 | 2022 | 81 | 1.410 |
Why?
|
| Surgical Procedures, Operative | 5 | 2021 | 182 | 1.380 |
Why?
|
| Public Health | 3 | 2020 | 129 | 1.330 |
Why?
|
| Water Sports | 2 | 2018 | 2 | 1.280 |
Why?
|
| General Surgery | 4 | 2020 | 229 | 1.280 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 746 | 1.270 |
Why?
|
| Intraabdominal Infections | 4 | 2017 | 10 | 1.260 |
Why?
|
| United States | 30 | 2024 | 6672 | 1.210 |
Why?
|
| Humans | 89 | 2024 | 86644 | 1.180 |
Why?
|
| Head Injuries, Penetrating | 3 | 2022 | 54 | 1.170 |
Why?
|
| Injury Severity Score | 9 | 2022 | 111 | 1.120 |
Why?
|
| Florida | 8 | 2019 | 55 | 1.040 |
Why?
|
| Prejudice | 3 | 2019 | 49 | 1.020 |
Why?
|
| Opioid-Related Disorders | 2 | 2024 | 161 | 0.970 |
Why?
|
| Sepsis | 2 | 2019 | 306 | 0.960 |
Why?
|
| Emergency Medical Services | 2 | 2023 | 209 | 0.960 |
Why?
|
| Community Participation | 2 | 2021 | 36 | 0.920 |
Why?
|
| Physicians | 2 | 2022 | 673 | 0.920 |
Why?
|
| Tranexamic Acid | 1 | 2023 | 25 | 0.910 |
Why?
|
| Cyclonic Storms | 2 | 2020 | 4 | 0.900 |
Why?
|
| Acidosis | 2 | 2013 | 55 | 0.880 |
Why?
|
| Prisons | 2 | 2019 | 12 | 0.870 |
Why?
|
| Retrospective Studies | 26 | 2023 | 8489 | 0.860 |
Why?
|
| Veins | 2 | 2013 | 94 | 0.850 |
Why?
|
| Internship and Residency | 5 | 2023 | 1004 | 0.840 |
Why?
|
| Child Abuse | 1 | 2022 | 78 | 0.810 |
Why?
|
| Peer Review, Research | 1 | 2021 | 36 | 0.800 |
Why?
|
| Sex Offenses | 2 | 2018 | 13 | 0.780 |
Why?
|
| Publishing | 1 | 2021 | 90 | 0.740 |
Why?
|
| Suicide | 1 | 2022 | 139 | 0.740 |
Why?
|
| Fractures, Bone | 2 | 2020 | 131 | 0.730 |
Why?
|
| Critical Care | 4 | 2020 | 370 | 0.720 |
Why?
|
| Male | 44 | 2023 | 40966 | 0.710 |
Why?
|
| Social Medicine | 1 | 2019 | 2 | 0.710 |
Why?
|
| Accidents, Traffic | 2 | 2018 | 94 | 0.710 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 44 | 0.700 |
Why?
|
| Human Rights | 1 | 2019 | 18 | 0.700 |
Why?
|
| Trauma Centers | 7 | 2021 | 116 | 0.690 |
Why?
|
| Female | 42 | 2023 | 44533 | 0.680 |
Why?
|
| Advisory Committees | 1 | 2019 | 90 | 0.680 |
Why?
|
| Intensive Care Units | 3 | 2018 | 373 | 0.670 |
Why?
|
| Hospitalization | 3 | 2018 | 849 | 0.650 |
Why?
|
| Health Equity | 1 | 2020 | 77 | 0.650 |
Why?
|
| Physician's Role | 1 | 2020 | 179 | 0.650 |
Why?
|
| Sports Equipment | 1 | 2018 | 1 | 0.650 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 316 | 0.640 |
Why?
|
| Tissue and Organ Procurement | 1 | 2022 | 311 | 0.640 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 301 | 0.640 |
Why?
|
| Postoperative Complications | 6 | 2021 | 2207 | 0.640 |
Why?
|
| Propensity Score | 2 | 2017 | 136 | 0.610 |
Why?
|
| Hospital Costs | 1 | 2018 | 105 | 0.610 |
Why?
|
| Motorcycles | 1 | 2017 | 11 | 0.600 |
Why?
|
| State Government | 1 | 2017 | 20 | 0.600 |
Why?
|
| Occupations | 1 | 2017 | 26 | 0.600 |
Why?
|
| Head Protective Devices | 1 | 2017 | 20 | 0.590 |
Why?
|
| Government Regulation | 1 | 2017 | 49 | 0.590 |
Why?
|
| Shock | 3 | 2022 | 42 | 0.590 |
Why?
|
| Adult | 29 | 2021 | 25648 | 0.590 |
Why?
|
| Craniocerebral Trauma | 1 | 2017 | 52 | 0.590 |
Why?
|
| Politics | 2 | 2019 | 50 | 0.590 |
Why?
|
| Acute Disease | 1 | 2019 | 826 | 0.580 |
Why?
|
| Mentoring | 1 | 2017 | 30 | 0.580 |
Why?
|
| Income | 1 | 2017 | 75 | 0.580 |
Why?
|
| Patient Selection | 1 | 2020 | 685 | 0.570 |
Why?
|
| Athletic Injuries | 1 | 2017 | 91 | 0.570 |
Why?
|
| Residence Characteristics | 2 | 2021 | 197 | 0.560 |
Why?
|
| Mass Screening | 2 | 2018 | 618 | 0.550 |
Why?
|
| Mining | 1 | 2015 | 3 | 0.550 |
Why?
|
| Child | 11 | 2023 | 6927 | 0.550 |
Why?
|
| Gold | 1 | 2015 | 41 | 0.530 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1169 | 0.520 |
Why?
|
| Appendicitis | 3 | 2021 | 62 | 0.520 |
Why?
|
| Venous Thromboembolism | 2 | 2018 | 153 | 0.510 |
Why?
|
| Young Adult | 16 | 2021 | 5976 | 0.500 |
Why?
|
| Emergency Service, Hospital | 2 | 2015 | 484 | 0.500 |
Why?
|
| Patient Handoff | 1 | 2015 | 93 | 0.490 |
Why?
|
| Vasoconstrictor Agents | 2 | 2019 | 53 | 0.480 |
Why?
|
| Environment | 1 | 2015 | 219 | 0.470 |
Why?
|
| Hospitals | 4 | 2022 | 294 | 0.460 |
Why?
|
| Arteries | 2 | 2020 | 176 | 0.460 |
Why?
|
| Shock, Traumatic | 1 | 2013 | 2 | 0.460 |
Why?
|
| Societies, Medical | 5 | 2021 | 572 | 0.450 |
Why?
|
| Police | 2 | 2021 | 23 | 0.450 |
Why?
|
| Socioeconomic Factors | 3 | 2022 | 567 | 0.450 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2012 | 29 | 0.440 |
Why?
|
| Incidence | 4 | 2019 | 1577 | 0.440 |
Why?
|
| Blood Specimen Collection | 1 | 2012 | 27 | 0.430 |
Why?
|
| Vision Screening | 1 | 2012 | 2 | 0.420 |
Why?
|
| National Health Programs | 1 | 2012 | 20 | 0.420 |
Why?
|
| beta-Lactams | 1 | 2012 | 14 | 0.420 |
Why?
|
| Cataract Extraction | 1 | 2012 | 31 | 0.410 |
Why?
|
| Blindness | 1 | 2012 | 41 | 0.410 |
Why?
|
| Wounds, Penetrating | 2 | 2021 | 46 | 0.400 |
Why?
|
| Middle Aged | 23 | 2021 | 25028 | 0.390 |
Why?
|
| Cataract | 1 | 2012 | 86 | 0.390 |
Why?
|
| Domestic Violence | 2 | 2021 | 24 | 0.390 |
Why?
|
| Risk Factors | 12 | 2023 | 5417 | 0.380 |
Why?
|
| Fibrinolytic Agents | 1 | 2012 | 202 | 0.380 |
Why?
|
| Brain Injuries | 1 | 2012 | 161 | 0.370 |
Why?
|
| Social Discrimination | 2 | 2021 | 5 | 0.370 |
Why?
|
| Poverty | 1 | 2012 | 173 | 0.370 |
Why?
|
| Hemorrhage | 2 | 2023 | 268 | 0.370 |
Why?
|
| Adolescent | 10 | 2021 | 8981 | 0.350 |
Why?
|
| Cause of Death | 2 | 2022 | 277 | 0.350 |
Why?
|
| Hate | 2 | 2019 | 3 | 0.350 |
Why?
|
| Health Personnel | 3 | 2022 | 202 | 0.340 |
Why?
|
| Pelvic Bones | 2 | 2020 | 44 | 0.340 |
Why?
|
| Body Mass Index | 1 | 2012 | 770 | 0.320 |
Why?
|
| Resuscitation | 2 | 2022 | 100 | 0.320 |
Why?
|
| Trauma Severity Indices | 2 | 2019 | 41 | 0.310 |
Why?
|
| Sexism | 4 | 2021 | 51 | 0.310 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2007 | 37 | 0.310 |
Why?
|
| Surveys and Questionnaires | 9 | 2021 | 2501 | 0.290 |
Why?
|
| Cuba | 2 | 2020 | 5 | 0.290 |
Why?
|
| Venezuela | 2 | 2019 | 9 | 0.280 |
Why?
|
| Colectomy | 2 | 2017 | 167 | 0.280 |
Why?
|
| Anti-Infective Agents | 2 | 2017 | 89 | 0.280 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2024 | 582 | 0.270 |
Why?
|
| Thoracic Injuries | 2 | 2016 | 32 | 0.270 |
Why?
|
| Infant | 3 | 2022 | 3047 | 0.270 |
Why?
|
| International Cooperation | 3 | 2016 | 127 | 0.260 |
Why?
|
| Child, Preschool | 3 | 2022 | 3612 | 0.260 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 1621 | 0.260 |
Why?
|
| Emergency Medical Technicians | 1 | 2004 | 14 | 0.260 |
Why?
|
| Stress, Psychological | 2 | 2020 | 313 | 0.260 |
Why?
|
| Appendectomy | 3 | 2021 | 33 | 0.260 |
Why?
|
| Prevalence | 5 | 2020 | 1239 | 0.260 |
Why?
|
| Minority Groups | 2 | 2023 | 137 | 0.250 |
Why?
|
| Aged | 14 | 2021 | 18415 | 0.250 |
Why?
|
| Infant, Newborn | 2 | 2022 | 2380 | 0.250 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 426 | 0.250 |
Why?
|
| Arabs | 1 | 2004 | 17 | 0.240 |
Why?
|
| Glasgow Coma Scale | 2 | 2021 | 65 | 0.240 |
Why?
|
| Length of Stay | 4 | 2021 | 702 | 0.240 |
Why?
|
| Trust | 1 | 2004 | 95 | 0.240 |
Why?
|
| Interpersonal Relations | 1 | 2004 | 170 | 0.230 |
Why?
|
| Program Evaluation | 2 | 2017 | 297 | 0.230 |
Why?
|
| Registries | 4 | 2021 | 702 | 0.220 |
Why?
|
| Sexual Harassment | 2 | 2020 | 9 | 0.220 |
Why?
|
| Survivors | 2 | 2021 | 226 | 0.220 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 120 | 0.220 |
Why?
|
| Analgesics, Opioid | 2 | 2024 | 413 | 0.210 |
Why?
|
| Aftercare | 1 | 2023 | 85 | 0.210 |
Why?
|
| Age Distribution | 1 | 2022 | 204 | 0.210 |
Why?
|
| History, 17th Century | 1 | 2021 | 12 | 0.200 |
Why?
|
| Time Factors | 4 | 2021 | 5210 | 0.200 |
Why?
|
| History, Medieval | 1 | 2021 | 11 | 0.200 |
Why?
|
| History, 18th Century | 1 | 2021 | 23 | 0.200 |
Why?
|
| Emergency Treatment | 1 | 2021 | 39 | 0.200 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 240 | 0.200 |
Why?
|
| Machine Learning | 2 | 2023 | 232 | 0.200 |
Why?
|
| Abdominal Abscess | 1 | 2021 | 22 | 0.200 |
Why?
|
| Medicine | 1 | 2022 | 89 | 0.200 |
Why?
|
| Population Surveillance | 1 | 2022 | 219 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2021 | 2261 | 0.190 |
Why?
|
| Social Problems | 1 | 2020 | 10 | 0.190 |
Why?
|
| Hemostatic Techniques | 1 | 2020 | 14 | 0.190 |
Why?
|
| History, 21st Century | 1 | 2021 | 175 | 0.190 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 30 | 0.190 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 32 | 0.190 |
Why?
|
| Betacoronavirus | 2 | 2020 | 258 | 0.190 |
Why?
|
| Specialties, Surgical | 1 | 2021 | 64 | 0.190 |
Why?
|
| Epidemics | 1 | 2020 | 33 | 0.180 |
Why?
|
| Mental Disorders | 1 | 2004 | 371 | 0.180 |
Why?
|
| Electric Power Supplies | 1 | 2020 | 9 | 0.180 |
Why?
|
| Bioethics | 1 | 2020 | 35 | 0.180 |
Why?
|
| Neurosurgical Procedures | 1 | 2022 | 213 | 0.180 |
Why?
|
| Pandemics | 3 | 2021 | 740 | 0.180 |
Why?
|
| Electricity | 1 | 2020 | 23 | 0.180 |
Why?
|
| Civil Defense | 1 | 2020 | 11 | 0.180 |
Why?
|
| Methylene Blue | 1 | 2019 | 18 | 0.180 |
Why?
|
| Thiamine | 1 | 2019 | 8 | 0.180 |
Why?
|
| Bias | 1 | 2020 | 127 | 0.180 |
Why?
|
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2019 | 7 | 0.180 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 37 | 0.180 |
Why?
|
| Vancomycin-Resistant Enterococci | 1 | 2019 | 13 | 0.180 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 63 | 0.180 |
Why?
|
| Interviews as Topic | 2 | 2015 | 319 | 0.180 |
Why?
|
| Advanced Trauma Life Support Care | 1 | 2019 | 1 | 0.180 |
Why?
|
| Biomarkers | 2 | 2023 | 1718 | 0.180 |
Why?
|
| Prospective Studies | 5 | 2021 | 4214 | 0.180 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2019 | 23 | 0.180 |
Why?
|
| Acinetobacter Infections | 1 | 2019 | 17 | 0.180 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 21 | 0.180 |
Why?
|
| Thrombectomy | 1 | 2021 | 158 | 0.180 |
Why?
|
| Klebsiella Infections | 1 | 2019 | 25 | 0.180 |
Why?
|
| Organ Dysfunction Scores | 1 | 2019 | 27 | 0.180 |
Why?
|
| Ontario | 2 | 2013 | 52 | 0.180 |
Why?
|
| Vena Cava, Inferior | 1 | 2021 | 143 | 0.180 |
Why?
|
| Acinetobacter baumannii | 1 | 2019 | 26 | 0.180 |
Why?
|
| Klebsiella pneumoniae | 1 | 2019 | 34 | 0.180 |
Why?
|
| Social Control, Formal | 1 | 2019 | 12 | 0.180 |
Why?
|
| Terminology as Topic | 1 | 2021 | 217 | 0.180 |
Why?
|
| Angiotensin II | 1 | 2019 | 94 | 0.180 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 20 | 0.180 |
Why?
|
| Harassment, Non-Sexual | 1 | 2019 | 1 | 0.180 |
Why?
|
| Enterococcus faecium | 1 | 2019 | 32 | 0.180 |
Why?
|
| Physical Abuse | 1 | 2019 | 4 | 0.180 |
Why?
|
| Equipment Failure | 1 | 2020 | 119 | 0.180 |
Why?
|
| Faculty, Medical | 2 | 2021 | 178 | 0.170 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 47 | 0.170 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3640 | 0.170 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 95 | 0.170 |
Why?
|
| Health Status Disparities | 1 | 2021 | 170 | 0.170 |
Why?
|
| Qualitative Research | 2 | 2021 | 256 | 0.170 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 73 | 0.170 |
Why?
|
| Shock, Septic | 1 | 2019 | 102 | 0.170 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 76 | 0.170 |
Why?
|
| Physicians, Women | 1 | 2019 | 53 | 0.170 |
Why?
|
| Disaster Planning | 1 | 2018 | 24 | 0.160 |
Why?
|
| Communication | 1 | 2022 | 441 | 0.160 |
Why?
|
| Stents | 1 | 2021 | 377 | 0.160 |
Why?
|
| Antioxidants | 1 | 2019 | 223 | 0.160 |
Why?
|
| Ships | 1 | 2018 | 5 | 0.160 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 243 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 865 | 0.160 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2017 | 5 | 0.160 |
Why?
|
| Fractures, Open | 1 | 2018 | 11 | 0.160 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 194 | 0.160 |
Why?
|
| Rectal Diseases | 1 | 2017 | 24 | 0.160 |
Why?
|
| Social Environment | 1 | 2019 | 188 | 0.160 |
Why?
|
| Upper Extremity | 1 | 2018 | 52 | 0.150 |
Why?
|
| Research Design | 1 | 2021 | 594 | 0.150 |
Why?
|
| Age Factors | 3 | 2021 | 1851 | 0.150 |
Why?
|
| Ileostomy | 1 | 2017 | 30 | 0.150 |
Why?
|
| Antimicrobial Stewardship | 1 | 2017 | 21 | 0.150 |
Why?
|
| Mandatory Programs | 1 | 2017 | 7 | 0.150 |
Why?
|
| Lower Extremity | 1 | 2018 | 84 | 0.150 |
Why?
|
| Colonic Diseases | 1 | 2017 | 65 | 0.150 |
Why?
|
| Health Planning Guidelines | 1 | 2017 | 24 | 0.150 |
Why?
|
| Spinal Fractures | 1 | 2018 | 75 | 0.150 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 255 | 0.150 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2017 | 52 | 0.150 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 62 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1823 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2021 | 376 | 0.150 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 141 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2022 | 610 | 0.140 |
Why?
|
| Health Care Costs | 1 | 2018 | 238 | 0.140 |
Why?
|
| Seasons | 1 | 2018 | 223 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 639 | 0.140 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 128 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 108 | 0.140 |
Why?
|
| Hypotension | 1 | 2016 | 70 | 0.140 |
Why?
|
| El Salvador | 1 | 2015 | 1 | 0.140 |
Why?
|
| Economic Development | 1 | 2015 | 2 | 0.140 |
Why?
|
| Quality of Health Care | 1 | 2019 | 380 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 184 | 0.140 |
Why?
|
| Nursing Staff, Hospital | 1 | 2015 | 42 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 636 | 0.130 |
Why?
|
| Focus Groups | 1 | 2015 | 155 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2017 | 695 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2015 | 107 | 0.130 |
Why?
|
| Thoracotomy | 1 | 2014 | 58 | 0.120 |
Why?
|
| Socioenvironmental Therapy | 1 | 2013 | 1 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 508 | 0.120 |
Why?
|
| APACHE | 2 | 2017 | 21 | 0.120 |
Why?
|
| Population Density | 1 | 2013 | 60 | 0.110 |
Why?
|
| Cities | 2 | 2023 | 40 | 0.110 |
Why?
|
| Brain | 1 | 2023 | 2216 | 0.110 |
Why?
|
| Sex Factors | 3 | 2021 | 1054 | 0.110 |
Why?
|
| Canada | 1 | 2013 | 204 | 0.110 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 21 | 0.110 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2012 | 4 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1036 | 0.110 |
Why?
|
| Piperacillin | 1 | 2012 | 7 | 0.110 |
Why?
|
| Caribbean Region | 1 | 2012 | 20 | 0.110 |
Why?
|
| Penicillanic Acid | 1 | 2012 | 11 | 0.110 |
Why?
|
| Latin America | 1 | 2012 | 14 | 0.110 |
Why?
|
| Disasters | 1 | 2012 | 20 | 0.110 |
Why?
|
| Developed Countries | 1 | 2012 | 24 | 0.100 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2012 | 25 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 159 | 0.100 |
Why?
|
| Developing Countries | 1 | 2012 | 71 | 0.100 |
Why?
|
| Anesthesia, General | 1 | 2012 | 114 | 0.100 |
Why?
|
| Telemedicine | 1 | 2013 | 169 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 6509 | 0.090 |
Why?
|
| Pregnancy | 1 | 2017 | 2894 | 0.090 |
Why?
|
| Blood Transfusion | 2 | 2022 | 157 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 394 | 0.090 |
Why?
|
| Patient Safety | 1 | 2012 | 212 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2012 | 225 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 371 | 0.080 |
Why?
|
| Chicago | 2 | 2023 | 1379 | 0.080 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 267 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 146 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2007 | 596 | 0.070 |
Why?
|
| Logistic Models | 2 | 2020 | 1186 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2019 | 814 | 0.060 |
Why?
|
| Reoperation | 1 | 2007 | 597 | 0.060 |
Why?
|
| Lawyers | 1 | 2023 | 2 | 0.060 |
Why?
|
| Israel | 1 | 2004 | 55 | 0.060 |
Why?
|
| Naloxone | 1 | 2023 | 59 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 2767 | 0.060 |
Why?
|
| Social Class | 1 | 2023 | 128 | 0.050 |
Why?
|
| Survival Rate | 2 | 2016 | 1863 | 0.050 |
Why?
|
| Health Status | 1 | 2023 | 360 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 51 | 0.050 |
Why?
|
| Homophobia | 1 | 2021 | 4 | 0.050 |
Why?
|
| Community-Based Participatory Research | 1 | 2021 | 36 | 0.050 |
Why?
|
| Emergencies | 1 | 2021 | 113 | 0.050 |
Why?
|
| Morals | 1 | 2022 | 92 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2021 | 150 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 7993 | 0.050 |
Why?
|
| Fracture Fixation | 1 | 2020 | 31 | 0.050 |
Why?
|
| Drainage | 1 | 2021 | 157 | 0.050 |
Why?
|
| Demography | 1 | 2020 | 177 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2023 | 300 | 0.050 |
Why?
|
| Leadership | 1 | 2021 | 134 | 0.050 |
Why?
|
| Pelvis | 1 | 2020 | 95 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 131 | 0.040 |
Why?
|
| Aggression | 1 | 2023 | 320 | 0.040 |
Why?
|
| Angiography | 1 | 2020 | 208 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 394 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 752 | 0.040 |
Why?
|
| Hospitals, Proprietary | 1 | 2018 | 3 | 0.040 |
Why?
|
| Terrorism | 1 | 2018 | 9 | 0.040 |
Why?
|
| Skull Fractures | 1 | 2018 | 24 | 0.040 |
Why?
|
| Motor Vehicles | 1 | 2018 | 18 | 0.040 |
Why?
|
| Organization and Administration | 1 | 2018 | 10 | 0.040 |
Why?
|
| Mass Casualty Incidents | 1 | 2018 | 12 | 0.040 |
Why?
|
| Poverty Areas | 1 | 2018 | 37 | 0.040 |
Why?
|
| Population Health | 1 | 2018 | 33 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1019 | 0.040 |
Why?
|
| Rural Population | 1 | 2018 | 136 | 0.040 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 35 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 238 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2018 | 154 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 115 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2020 | 710 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 72 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 143 | 0.030 |
Why?
|
| Global Health | 1 | 2017 | 193 | 0.030 |
Why?
|
| Medicaid | 1 | 2018 | 217 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1538 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2705 | 0.030 |
Why?
|
| Critical Illness | 1 | 2017 | 294 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1673 | 0.030 |
Why?
|
| Tetanus Toxoid | 1 | 2012 | 10 | 0.030 |
Why?
|
| Haiti | 1 | 2012 | 21 | 0.030 |
Why?
|
| Anesthesia, Conduction | 1 | 2012 | 18 | 0.030 |
Why?
|
| Medical Records | 1 | 2012 | 119 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2012 | 71 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 130 | 0.020 |
Why?
|
| Infection Control | 1 | 2012 | 115 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2601 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 3679 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2012 | 428 | 0.020 |
Why?
|